Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
October 14, 2019

Eli Lilly gets FDA approval for migraine drug Reyvow

Eli Lilly has secured approval from the US Food and Drug Administration (FDA) for its Reyvow (lasmiditan) for the acute treatment of migraine.

Continue
Image: Eli Lilly and Company's Corporate Centre in Indianapolis, Indiana. Photo: courtesy of Momoneymoproblemz.
October 11, 2019

Belgium’s UCB to buy Ra Pharmaceuticals for $2.1bn

Image: UCB has agreed to acquire Ra Pharmaceuticals. Photo: courtesy of Adam Radosavljevic from Pixabay.
October 10, 2019

Viela Bio, Mitsubishi Tanabe sign licensing deal for inebilizumab

Image: Mitsubishi Tanabe strikes deal with Viela Bio for the licensing of inebilizumab. Photo: courtesy of Kirakirameister/Wikipedia.org.

Contracts

May 22, 2019

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

Image: WuXi Vaccines will build an integrated vaccine manufacturing facility. Photo: courtesy of Arek Socha / Pixabay.

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

GeoVax, Leidos expand collaboration to malaria vaccines

World’s largest pharmaceutical firm selects ValGenesis to standardize corporate validation process enterprise-level

Deals

Deals October 10, 2019

NSF International purchases majority stake in Amarex CRO

Pharmaceutical Business Review

Akcea to license investigative antisense therapy AKCEA-ANGPTL3-LRx to Pfizer

Lantheus to acquire oncology company Progenics Pharmaceuticals

Sobi to buy Dova Pharmaceuticals in $915m deal

Popular

  1. Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH
  2. Celsius Therapeutics signs collaboration agreement with Janssen to identify response biomarkers for ulcerative colitis
  3. Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
  4. VALBIOTIS announces positive results from phase IIA trial of VALEDIA in prediabetics
  5. GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis

PRESS RELEASES

Be Part of the Biggest Nutraceutical Event in North America with Softigel® by Procaps
Be Part of the Biggest Nutraceutical Event in North America with Softigel® by Procaps
Particle Separation of Pharmaceutical Powders with Multi Deck Separator
Particle Separation of Pharmaceutical Powders with Multi Deck Separator
Wade Wirta Announced as N-SIDE US Managing Director
Wade Wirta Announced as N-SIDE US Managing Director
Enamine and ChemAxon to Create Web-Based Search in Immense Chemical Space
Enamine and ChemAxon to Create Web-Based Search in Immense Chemical Space
Global Standards Developer ASTM International Schedules Board Meeting and Events
Global Standards Developer ASTM International Schedules Board Meeting and Events

Suppliers

Whitepapers

Azide-linkers for Drug Design
Azide-linkers for Drug Design
Unnatural Amino Acids
Unnatural Amino Acids
Heterocyclic Sulfonyl Fluorides
Heterocyclic Sulfonyl Fluorides